Delivery Order SPE2DB20D2014-SPE2DB25FA69X

Award Date 1/3/25
Potential Completion Date 1/6/25
Potential Value $44K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) for the delivery of 4566771243 XELJANZ XR 11 MG TABLET UU 30S. The firm-fixed-price delivery order has a ceiling value of $8,723.07 and a completion date of December 20, 2024. The contract does not have a set-aside designation, indicating an open competition. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $10,008.51 firm fixed-price delivery order is for the supply of XELJANZ XR 11 MG TABLET UU 30S, a medication. The contract has an ultimate completion date of December 13, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $40,673.92 firm fixed price delivery order is for the supply of XELJANZ XR 11 MG tablets. The contract has an ultimate completion date of January 6, 2025. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
This federal contract award is to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, from the Defense Logistics Agency (DLA) for the delivery of XELJANZ 5 MG TABLET UU 60S, a pharmaceutical product. The contract is a $3,461.50 Firm Fixed Price Delivery Order with a completion date of June 5, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) for the delivery of Xeljanz XR 11 mg tablets. The $3,863.44 firm-fixed-price delivery order has an ultimate completion date of October 29, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $24,676.40 firm-fixed-price delivery order is for the supply of XELJANZ XR 11 MG TABLET, a specialty pharmaceutical product. The contract has an ultimate completion date of December 5, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is a delivery order valued at $34,035.77 under an Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) Troop Support Medical. The contract involves supplying XELJANZ XR 11 MG TABLET, a specialty medication, to support military healthcare programs. Amerisourcebergen holds a $999,999,999 IDC with the DLA Troop Support Medical for providing a comprehensive range of pharmaceutical...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $45,772.55 firm fixed-price delivery order is for the supply of XELJANZ XR 11 MG TABLET UU 30S, a medication used to treat various medical conditions. The contract has an ultimate completion date of December 17, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) Troop Support Medical. The $8,845.90 firm-fixed-price delivery order is for the supply of the medication Xeljanz XR 11 mg tablets. The contract has an ultimate completion date of October 24, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) Troop Support Medical. The $1,927.28 firm fixed price delivery order is for XELJANZ 5 MG TABLET UU 60S, a pharmaceutical product. The award has an ultimate completion date of December 31, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing...
  • SPE2DB20D2014
    Indefinite Delivery Contract
  • SPE2DB20D2014-SPE2DB25FA69X
    Delivery Order

This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) for the delivery of XELJANZ XR 11 MG TABLET UU 30S. The firm-fixed-price delivery order has a ceiling value of $43,829.52 and an ultimate completion date of January 6, 2025. The contract is not designated as a set-aside.

Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The company also maintains a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at $750,000 through May 2024, which covers similar medical products and prescription drugs.

Generated 4/4/25, 9:49 AM